Gsk Plc Stock Analysis
| GLAXF Stock | USD 16.94 0.08 0.47% |
GSK plc is overvalued with Real Value of 15.24 and Hype Value of 16.94. The main objective of GSK Plc pink sheet analysis is to determine its intrinsic value, which is an estimate of what GSK plc is worth, separate from its market price. There are two main types of GSK Plc's stock analysis: fundamental analysis and technical analysis.
The GSK Plc pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and GSK Plc's ongoing operational relationships across important fundamental and technical indicators.
GSK |
GSK Pink Sheet Analysis Notes
About 41.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.11. GSK plc last dividend was issued on the 23rd of February 2023. The entity had 4:5 split on the 19th of July 2022. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc is traded on OTC Exchange in the United States.The quote for GSK plc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about GSK plc call the company at 44 20 8047 5000 or check out https://www.gsk.com.GSK plc Investment Alerts
| GSK plc generated a negative expected return over the last 90 days | |
| GSK plc has high historical volatility and very poor performance |
GSK Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 73.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GSK Plc's market, we take the total number of its shares issued and multiply it by GSK Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.GSK Profitablity
The company has Profit Margin (PM) of 0.51 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.Technical Drivers
As of the 22nd of November, GSK Plc retains the Risk Adjusted Performance of (0.05), coefficient of variation of (1,406), and Market Risk Adjusted Performance of 0.763. GSK Plc technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out GSK plc standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if GSK Plc is priced correctly, providing market reflects its last-minute price of 16.94 per share. Given that GSK plc has information ratio of (0.11), we strongly advise you to confirm GSK plc's regular market performance to make sure the company can sustain itself at some point in the future.GSK plc Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. GSK Plc middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for GSK plc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
GSK Plc Outstanding Bonds
GSK Plc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GSK plc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GSK bonds can be classified according to their maturity, which is the date when GSK plc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
GSK Plc Predictive Daily Indicators
GSK Plc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GSK Plc pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
GSK Plc Forecast Models
GSK Plc's time-series forecasting models are one of many GSK Plc's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GSK Plc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About GSK Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how GSK Plc prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GSK shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as GSK Plc. By using and applying GSK Pink Sheet analysis, traders can create a robust methodology for identifying GSK entry and exit points for their positions.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding GSK Plc to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Complementary Tools for GSK Pink Sheet analysis
When running GSK Plc's price analysis, check to measure GSK Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GSK Plc is operating at the current time. Most of GSK Plc's value examination focuses on studying past and present price action to predict the probability of GSK Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GSK Plc's price. Additionally, you may evaluate how the addition of GSK Plc to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |